Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study to Assess the Safety and Immunogenicity of VAXCHORA (Cholera Vaccine, Live, Oral) in Children 2 to <18 Years of Age

NCT03220737 is registered in ClinicalTrials.gov with Bavarian Nordic as lead sponsor.

NCT NCT03220737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03220737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study to Assess the Safety and Immunogenicity of VAXCHORA (Cholera Vaccine, Live, Oral) in Children 2 to <18 Years of Age
Lead sponsor
Bavarian Nordic
Phase
Phase 4
Overall status
Completed
Start date
July 21, 2017
Completion date
March 6, 2020
Enrollment
550 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cholera (disorder)